155 related articles for article (PubMed ID: 17409506)
1. Pharmacokinetic study of triptolide, a constituent of immunosuppressive chinese herb medicine, in rats.
Shao F; Wang G; Xie H; Zhu X; Sun J; A J
Biol Pharm Bull; 2007 Apr; 30(4):702-7. PubMed ID: 17409506
[TBL] [Abstract][Full Text] [Related]
2. Effects of triptolide on pharmacokinetics of amlodipine in rats by using LC-MS/MS.
Zhang C; Gao Z; Niu L; Chen X
Pharm Biol; 2018 Dec; 56(1):132-137. PubMed ID: 29385884
[TBL] [Abstract][Full Text] [Related]
3. Gender Differences in the Toxicokinetics of Triptolide after Single- and Multiple-dose Administration in Rats.
Liu L; Zhang J; Wang Z; Xu D; Jiang Z; Wang T; Ju W; Zhang L
Drug Res (Stuttg); 2015 Nov; 65(11):602-6. PubMed ID: 25647231
[TBL] [Abstract][Full Text] [Related]
4. Excretion of [3H]triptolide and its metabolites in rats after oral administration.
Liu J; Zhou X; Chen XY; Zhong DF
Acta Pharmacol Sin; 2014 Apr; 35(4):549-54. PubMed ID: 24632843
[TBL] [Abstract][Full Text] [Related]
5. Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats.
Xue M; Zhao Y; Li XJ; Jiang ZZ; Zhang L; Liu SH; Li XM; Zhang LY; Yang SY
Eur J Pharm Sci; 2012 Nov; 47(4):713-7. PubMed ID: 22677813
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatographic/mass spectrometry assay of triptolide in dog plasma and its application to pharmacokinetic study.
Shao F; Wang G; Sun J; Xie H; Li H; Liang Y; Zhang R; Zhu X
J Pharm Biomed Anal; 2006 May; 41(2):341-6. PubMed ID: 16413988
[TBL] [Abstract][Full Text] [Related]
7. Male reproductive toxicity and toxicokinetics of triptolide in rats.
Ni B; Jiang Z; Huang X; Xu F; Zhang R; Zhang Z; Tian Y; Wang T; Zhu T; Liu J; Zhang L
Arzneimittelforschung; 2008; 58(12):673-80. PubMed ID: 19202740
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics of triptolide in Beagle dogs].
Shao F; Wang GJ; Sun JG; Xie HT; Zhang R; Zhu XY
Yao Xue Xue Bao; 2007 Jan; 42(1):61-5. PubMed ID: 17520809
[TBL] [Abstract][Full Text] [Related]
9. Identification of in vivo and in vitro metabolites of triptolide by liquid chromatography-tandem mass spectrometry.
Peng ZH; Wang JJ; Du P; Chen Y
J Pharm Biomed Anal; 2012 Nov; 70():624-30. PubMed ID: 22824635
[TBL] [Abstract][Full Text] [Related]
10. Synchronous measuring of triptolide changes in rat brain and blood and its application to a comparative pharmacokinetic study in normal and Alzheimer's disease rats.
Zhu S; Wang X; Zheng Z; Zhao XE; Bai Y; Liu H
J Pharm Biomed Anal; 2020 Jun; 185():113263. PubMed ID: 32203895
[TBL] [Abstract][Full Text] [Related]
11. Influence of astragaloside IV on pharmacokinetics of triptolide in rats and its potential mechanism.
Gao J; Zeng X; Zhao W; Chen D; Liu J; Zhang N; Duan X
Pharm Biol; 2020 Dec; 58(1):253-256. PubMed ID: 32233814
[No Abstract] [Full Text] [Related]
12. Kinetic release of triptolide after injection of renal-targeting 14-succinyl triptolide-lysozyme in a rat kidney study by liquid chromatography/mass spectrometry.
Zheng Q; Ye L; Gao R; Han J; Xiong M; Zhao D; Gong T; Zhang Z
Biomed Chromatogr; 2007 Jul; 21(7):724-9. PubMed ID: 17370252
[TBL] [Abstract][Full Text] [Related]
13. CYP3A4 inducer and inhibitor strongly affect the pharmacokinetics of triptolide and its derivative in rats.
Xu Y; Zhang YF; Chen XY; Zhong DF
Acta Pharmacol Sin; 2018 Aug; 39(8):1386-1392. PubMed ID: 29283173
[TBL] [Abstract][Full Text] [Related]
14. Effects of puerarin on the pharmacokinetics of triptolide in rats.
Wang Q; Wu Y; Xiang F; Feng Y; Li Z; Ding Y
Pharm Biol; 2019 Dec; 57(1):407-411. PubMed ID: 31230510
[No Abstract] [Full Text] [Related]
15. Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats.
Zhang C; Peng F; Liu W; Wan J; Wan C; Xu H; Lam CW; Yang X
Int J Nanomedicine; 2014; 9():1049-63. PubMed ID: 24591827
[TBL] [Abstract][Full Text] [Related]
16. Absorption and Metabolism Characteristics of Triptolide as Determined by a Sensitive and Reliable LC-MS/MS Method.
Gong X; Chen Y; Wu Y
Molecules; 2015 May; 20(5):8928-40. PubMed ID: 25993421
[TBL] [Abstract][Full Text] [Related]
17. Transdermal delivery of triptolide-phospholipid complex to treat rheumatoid arthritis.
Liu XY; Pei WJ; Wu YZ; Ren FL; Yang SY; Wang X
Drug Deliv; 2021 Dec; 28(1):2127-2136. PubMed ID: 34617835
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of triptolide-coated stent on decreasing inflammation and attenuation of intimal hyperplasia in a pig after coronary angioplasty.
Hailong Ge ; Yujie Zhou ; Hanying Ma ; Lei Liu ; Xiaoli Liu ; Zhijian Wang ; Shiwei Yang ; Bin Nie ; Jia D
Angiology; 2011 Apr; 62(3):265-9. PubMed ID: 21406423
[TBL] [Abstract][Full Text] [Related]
19. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis.
Gu Y; Tang X; Yang M; Yang D; Liu J
Int J Pharm; 2019 Jan; 554():235-244. PubMed ID: 30423415
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Pharmacokinetics of Triptolide: A Potential Antitumor Drug.
Song W; Liu M; Wu J; Zhai H; Chen Y; Peng Z
Curr Drug Metab; 2019; 20(2):147-154. PubMed ID: 30112986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
